Connect with us

Media OutReach

Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha

Published

on

HONG KONG SAR – EQS Newswire – 2 July 2025 – On June 27, 2025, Uni-Bio Science Group Limited (the “Group”)grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end series GeneQueens of 肌顏態® and the medical device brand 金因敷®. Many experts, KOLs and partners attended the event. This launch not only showcased the Group’s achievements in R&D, but also marked the comprehensive layout in the “drug, medical device and Aesthetics” field.

Photo: Group photo at the launch

1、 High-end medical aesthetics: GeneQueens series

At the launch, the Group unveiled the high-end series of 肌顏態® -——GeneQueensTM (Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating cell regeneration, it helps users restore their youthful and healthy skin condition.

Photo: GeneQueens product image
Photo: GeneQueens product image

GeneQueensTM sets a new standard for anti-aging and repair by adding three core ingredients in sufficient quantities. Skbrella FN, as a key ingredient for cell repair, can accelerate the healing of skin wounds and promote the adhesion and migration of new cells. III Collagen strongly fills the skin structure, significantly enhancing elasticity and firmness. XVII Collagen can strengthen the connection between the epidermis and dermis, and consolidate the youthful foundation of the skin.

In addition, GeneQueens adopts a sterile and preservative-free formula, relying on high-purity raw materials and patented technology, providing users with an “instant enjoyment” precise and efficient experience. Its unique formula and outstanding efficacy were highly recognized by many experts on the spot.

2金因敷 showcased a variety of new products

Meanwhile, the Group also launched several new products of its medical device brand – 金因敷®, focusing on the professional repair field of medical aesthetics.

Photo: 金因敷 series product picture
Photo: 金因敷 series product picture

金因敷® complies with strict clinical trials and quality inspections to ensure its safety and effectiveness. The product adopts a high-purity non-allergenic formula, which can moisturize and accelerate wound repair. It also uses an exclusive cooling technology to relieve postoperative swelling and pain, providing a professional solution for sensitive skin and post-medical procedure care.

3The latest research data was presented at CSD2025

It is worth mentioning that 肌顏態® also showcased the research data of “The Efficacy Study of Fibronectin in the Repair of Skin Barrier Damage for the post-medical procedure” jointly conducted with the Cosmetics Testing Center of the Dermatology Hospital of Southern Medical University in the poster area of the 30th Academic Conference of the Chinese Medical Association (CSD2025). This is not only an endorsement of the Group’s research capabilities, but also provides experts and scholars in the industry with an opportunity to gain a deeper understanding of the 肌顏態® technology and products.

As an annual grand event in the field of dermatology and venereology in China, CSD2025 brings together authoritative experts and scholars in dermatology across the country, presenting multi-dimensional academic achievements and exchanges of ideas. The poster area is one of the core venues of the academic annual conference. Posters are not only an important way for researchers to showcase their scientific research achievements, but also a key link in promoting the dissemination of academic ideas and the feedback of clinical practice.

Photo: The research poster of 肌顏態 at the CSD 2025
Photo: The research poster of 肌顏態 at the CSD 2025

4Academic speeches by several experts

Several clinical experts at the launch further recognized the significant clinical value of 肌顏態® and 金因敷®. The experts highlighted that 肌顏態®‘ s patented ingredient, Skbrella FN, demonstrates immense potential in improving damaged sensitive skin barriers, reducing inflammatory erythema, alleviating discomfort sensations such as burning, tightness and itching, as well as enhancing post-laser repair and healing.

In the clinical observations over the past few months, many patients treated with 肌顏態® have achieved remarkable therapeutic effects. The symptoms of anesthetic allergy have been rapidly relieved, the inflammatory pigmentation post-laser has significantly improved, the skin barrier has been repaired, and the patient satisfaction rate is extremely high. 金因敷® can effectively reduce redness, swelling and pain for post-medical procedures, accelerate wound healing and shorten the recovery time.

Photo 1: 肌顏態 use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University; Photo 2: 肌顏態 use case sharing by Professor Ge Lan, from The First Affiliated Hospital of Army Medical University; Photo 3: Fibronectin clinical trial results sharing by Professor Ye Li, Head of Cosmetics Testing Center at Dermatology Hospital of Southern Medical University; Photo 4: Mr. Du Wei, CEO of Cosmetics News & Cosmetics Business Online, analyzes cosmetics industry development trends
Photo 1: 肌顏態 use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University; Photo 2: 肌顏態 use case sharing by Professor Ge Lan, from The First Affiliated Hospital of Army Medical University; Photo 3: Fibronectin clinical trial results sharing by Professor Ye Li, Head of Cosmetics Testing Center at Dermatology Hospital of Southern Medical University; Photo 4: Mr. Du Wei, CEO of Cosmetics News & Cosmetics Business Online, analyzes cosmetics industry development trends

6The signing ceremony reflects the market potential

Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, emphasized: ” We have always adhered to the standards of biopharmaceuticals in creating skin care products. The release of GeneQueens and 金因敷 is an important milestone in building the “Drugs, Medical device and Aesthetics” strategy and creating a full-cycle skin care solution, aiming to meet consumers’ increasingly refined skin health needs. ”

Photo: Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, addressing the launch event.
Photo: Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, addressing the launch event.

Furthermore, Ms. Liu Yihua, President of Global Cosmetics Group, attended the launch as an important guest. Uni-Bio Science Group and Global Cosmetics Group have jointly established a medical research co-creation biological platform. Utilizing gene-editing biosynthesis technology, the platform has launched Skbrella FN – a highly bioactive recombinant human fibronectin known as “皮優理”.

The launch also witnessed a grand strategic signing ceremony. The Group has achieved in-depth cooperation with many well-known medical aesthetics chain institutions and well-known agents. This signing is not only a high recognition of the quality and market potential of GeneQueens and 金因敷®, but also a key step for the Group to accelerate commercialization and expand channels. Through strong alliances with leading channel partners, the Group will reach the core consumers and ensure the rapid release of huge commercial value.

Photo: Group photo of the strategic signing ceremony
Photo: Group photo of the strategic signing ceremony

The successful holding of this launch not only marks a crucial step for the Group in medical aesthetics and medical devices, but also demonstrates the Group’s in-depth layout and forward-looking vision in the “Drugs, Medical device and Aesthetics” strategy. In the future, the Group will continue to be guided by technology and oriented towards clinical value, accelerate product innovation and technological upgrading, constantly enrich pipeline, and meet the growing market demands.Hashtag: #UniBioScienceGroup

The issuer is solely responsible for the content of this announcement.

Advertisement

Media OutReach

New Documentary A MONA LISA OBSESSION from Discovery to debut December 14 in Southeast Asia

Published

on

SINGAPORE – Media OutReach Newswire – 10 December 2025 – A brand-new documentary A Mona Lisa Obsession explores various perspectives of the Mona Lisa, an iconic masterpiece by Leonardo da Vinci, set to air in Southeast Asia on the Discovery Channel on Thursday, December 11 2025 at 7:10 PM and on Discovery Asia on Sunday, December 14 at 9:00 PM.

A Mona Lisa Obsession touches on the origins of the Mona Lisa, from the Italian Renaissance, and the painting’s passage through France with King Francis l and Napoleon Bonaparte, to the Louvre – the documentary also zooms in on a rare private art collection in Taiwan which includes a likeness of the painting of Mona Lisa, a work of art that some consider to be a youthful depiction reminiscent of Mona Lisa.

Owned by Frank Huang, an art collector and Taiwanese technology leader from Taiwan, this depiction of the Mona Lisa from his private collection adds a unique perspective to the ongoing conversation surrounding one of Leonardo da Vinci’s most iconic works.

The Mona Lisa has long captivated the world with her enigmatic smile and mysterious gaze – over centuries, many artistic interpretations inspired by the Mona Lisa have emerged, with scholars discovering more hidden details and subtle symbols, fueling the fascination of the original painting.

Catch A Mona Lisa Obsession in Southeast Asia on the Discovery Channel, Thursday, December 11, 2025 at 7:10 PM SGT and on Discovery Asia on Sunday, December 14 at 9:00 PM SGT.

****

Note to editors:

  • Watch highlights here
  • Download stills here

The issuer is solely responsible for the content of this announcement.

About Discovery Channel

Across every platform, Discovery Channel is dedicated to connecting audiences who have a passion for adventure and crave a connection to the world around them. Popular series including Deadliest Catch, Expedition Unknown and Gold Rush, along with Shark Week, the annual tentpole programming event, serve as trusted portals that transport viewers directly into thrilling, real, high stakes moments. Through smart, authentic characters whose stories inform and inspire, Discovery celebrates the men and women who will stop at nothing to explore new spaces and achieve their dreams. For more information, please visit

Continue Reading

Media OutReach

Financial Stress Keeps Singapore Awake, while Overall Well-Being in APAC Lags Behind Global Peers

Published

on

Promotion of exercise culture and therapy may boost physical and mental health

SINGAPORE – Media OutReach Newswire – 10 December 2025 – Despite mounting stress due to sustained concerns with the cost of living, vitality and overall well-being levels in Singapore remain consistent with last year. However, stress has a demonstrable effect on respondents’ mental and physical well-being, signaling the importance of a holistic approach to healthcare that encompasses both aspects.

The Singapore report of the Cigna Healthcare International Health Study 2025, released today encompasses more than 11,000 respondents across 13 markets, including 1,000 in Singapore and 4,000 across the Asia-Pacific region. The study reveals that physical, mental and financial well-being are the three aspects prioritized by Singapore residents. However, financial well-being is ranked the lowest with almost four in 10 (39%) rating their financial health as “fair” or “poor”.

Raymond Ng, CEO & Country Manager, Cigna Healthcare Singapore & Australia said: “Health and vitality are key to building resilient communities. It promises the well-being of our workforce and enables us to grow and prosper as a society. While vitality and well-being levels held firm among Singapore residents, more needs to be done in today’s uncertain environment to tackle stressors that can negatively impact their physical and mental well-being.”

The key indicators of vitality and well-being in Singapore are as follows:

Vitality Score Overall Well-Being

(% rating as “excellent” or “very good”)

Top Three Areas of Well-Being

(% rating as “excellent” or “very good” in 2025)

2025: 61.2

2024: 61.4

2025: 34%

2024: 33%

Family well-being: 44%

Mental well-being: 36%

Physical well-being: 34%


On a regional level, overall well-being in Asia Pacific lags behind the global average, with less than three in 10 (28%) Asia-Pacific respondents rating their overall well-being as “excellent” or “very good”, compared to four in 10 (41%) globally. While physical and mental well-being are the two most important aspects of well-being for respondents globally, financial well-being is more important for those in Asia Pacific, coming in as the third most important aspect. With financial well-being remaining the weakest aspect across the globe, there is a pressing need for governments and organizations to render support to address financial concerns.

Robert Peat, Chief Executive Officer, Asia Pacific, Cigna Healthcare said: “Asia Pacific continues to be one of the fastest growing regions in the world. To sustain this momentum, communities and employers need to recognize that healthy people are the foundation of a healthy economy and implement measures to close the gaps in their well-being.”

Sleepless in Singapore: Financial stress as the sleep killer

While mental well-being in Singapore remains stable with more than a third of respondents rating it as “excellent” or “very good” this year, eight in 10 (79%) respondents are stressed. Their greatest stressors are the current cost of living (53%); uncertainty about the future (47%); and personal finance (43%).

Stress affects more than mental and emotional health and can have huge implications on physical well-being. Our study reveals that disrupted sleep is the most common effect of stress among respondents in the nation, with close to half (48%) of respondents who are stressed reporting this effect, compared to 38% regionally.

Therapy remains underused by Singapore respondents. Despite nearly half (49%) of respondents reporting being negatively impacted by poor mental health, nearly nine in 10 (89%) say they did not receive counselling or therapy in the past 12 months, with 77% believing they do not need it. Given the impacts of stress and poor mental health on physical and overall well-being, more efforts are needed to raise awareness about the benefits of therapy and destigmatize seeking help.

Exercise culture runs strong in Singapore

More than a quarter (26%) of respondents in Singapore rate their exercise habits as “excellent” or “very good”.

When asked how they manage their weight, two-thirds (66%) said they exercise regularly, higher than the Asia-Pacific average of 61%; with only 4% of Singapore respondents turning to medication for weight management. The findings underscore a relatively strong exercise culture and the prioritization of healthy habits among those living in the nation. Communities and organizations may leverage the growing fitness trend to enhance physical well-being.

Cautious optimism around AI in healthcare

Close to half (47%) of Singapore respondents are positive about the impact of AI on healthcare, with 45% expecting it will reduce wait times within three years. This could have an outsized impact in Singapore, as respondents here are 29% more likely to have delayed or avoided getting care due to concern with wait times than their regional counterparts.

Additionally, almost half of Singapore respondents (48%) mention a reduction in human interaction as an expected change with the advent of AI. The challenge ahead is striking the right balance between efficiency and empathy.

The full findings of the report are available here.
Hashtag: #CignaHealthcare #CignaHealthcareInternationalHealthStudy #Health #Wellness #Wellbeing




The issuer is solely responsible for the content of this announcement.

Cigna Healthcare Singapore

Cigna Healthcare is a division of The Cigna Group, a global health company committed to creating a better future built on the health and vitality of every individual and every community. Cigna Healthcare is a health benefits provider that advocates for better health through every stage of life. We guide our customers through the healthcare system, empowering them with the information and insight they need to make the best choices for improving their health and vitality.

Cigna Healthcare Singapore is a strong believer of total health and wellness and prides itself on delivering personalized solutions for the health of our clients and customers. To achieve this, Cigna Healthcare Singapore works as one global team and in close partnership with its customers, network providers and communities to understand and address their diverse needs. Learn more at

Continue Reading

Media OutReach

SWISS REJU wins “JESSICA Best AI Body Slimming Award” with INDIBA

Published

on

HONG KONG SAR – Media OutReach Newswire – 10 December 2025 – SWISS REJU has earned “Best AI Slimming Treatment Award” at the prestigious JESSICA Beauty and Wellness Awards, honouring exceptional mastery of artificial intelligence in the beauty industry. SWISS REJU also announces the official launch of INDIBA, an FDA and CE approved technology that helps to burn visceral fat and contour the body, creating an even stronger technical offering for its signature, multi-award winning program “SWISS REJU K-Lipolysis”.

SWISS REJU won the “Best AI Slimming Treatment Award” at the prestigious JESSICA Beauty and Wellness Awards

The JESSICA Beauty and Wellness Awards celebrate excellence across luxury beauty, healthcare and wellness. It is one of the most recognized beauty industry awards in Hong Kong. The organizer, JESSICA, is a major lifestyle and media company. For over 25 years, JESSICA has been reporting on fashion, lifestyle and business, as one of the most trustworthy and influential media sources in Hong Kong.

“We’re incredibly fortunate to win this new, Best AI Slimming Award with JESSICA,” said the spokesperson for SWISS REJU. “Our goal was to provide our guests with top medical aesthetic technologies. Platforms like BTL EXION and INDIBA, are exactly the type of top medical technologies which SWISS REJU is heavily investing in. The breathtaking results powered by AI, reflect the endless possibilities new technologies can bring to the beauty and slimming field”

The JESSICA Beauty and Wellness Awards is extremely selective and has a rigorous nominations and editorial selection process. Only brands that have been proven to provide genuine service and excellent results are eligible to compete. Amongst the Winners this year, are Australian organic brand “CANVAS” and Japanese household name “Panasonic VITALIFT” beauty appliances.

SWISS REJU, with its heavy investment in new and prestigious technologies such as INDIBA (recently approved in Europe under the Medical Device Regulation), offers a seamless blend of traditional wellness and innovation, allowing guests to experience what many considered to be one of the most effective slimming treatments in Hong Kong. INDIBA with its trademark Proionic 448khz technology, is loved by the Top 1% most influential users in the world, amongst them European royalties, celebrity footballers and international singers.

The recognition of this major annual Award, reaffirms SWISS REJU’s commitment to exceptional technology. It is the 12th annual award won by the brand, representing a new record.

SWISS REJU and integrative power of cutting edge technologies

SWISS REJU’s trademarked “K-Lipolysis” body contouring program offers winning technologies including INDIBA, BTL EXION, Winback, ATP LIPO X, amongst others. It is the unique contouring solution beauty lovers are craving for.
Hashtag: #SWISSREJU #熱光溶脂

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending